What is phenylpiracetam?
Phenylpiracetam is a synthetic racetam. Its chemical name is 2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide. It is piracetam with a phenyl group on ring carbon 4. Its International Nonproprietary Name is fonturacetam. It is also called carphedon and 4-phenylpiracetam (PubChem CID 132441). A 1983 Russian paper called it a new phenyl analog of piracetam (Bobkov et al., 1983). A 2010 review called it more potent than piracetam (Malykh and Sadaie, 2010).
In Russia, clinical papers call it Phenotropil. It is a prescription drug there but is not authorised in the EU or Australia (Vanhee et al., 2025). Nor is it approved in the United States (Cohen et al., 2021). The World Anti-Doping Agency lists it as a stimulant banned in competition. Disguised Alpha supplies phenylpiracetam as an aerosol spray, 250MCG per spray with an estimated 50 sprays per bottle, for laboratory research use only. Nothing on this page is guidance for use in people.
Phenylpiracetam reference data
| Property | Value |
|---|---|
| Name | Phenylpiracetam |
| Also called | Fonturacetam (INN), carphedon, 4-phenylpiracetam, Phenotropil, UNII 99QW5JU66Y (PubChem CID 132441) |
| Structure | A 2-pyrrolidinone ring with an acetamide on its nitrogen, as in piracetam. A phenyl group sits on ring carbon 4. It has one stereocenter ((R)-form PubChem CID 781883, (S)-form CID 781884) |
| Compound class | Racetam, a 4-phenyl analog of piracetam; WADA class S6.A stimulant |
| Molecular formula | C₁₂H₁₄N₂O₂ |
| Molecular weight | 218.25 g/mol |
| Form | Aerosol spray, pre-formulated: 250MCG per spray, an estimated 50 sprays per bottle |
| Testing | Check the product page and the COA portal for your lot's certificate |
The formula and weight are from the aerosol product page. So are the format and storage. PubChem CID 132441 matches the formula and weight. It also supplies the synonyms and structure. It does not state the stereochemistry. Check the certificate for your lot.
See it beside the other compounds on this site in the peptide molecular weight reference table.
What the research covers
Published work on phenylpiracetam falls into six areas. Each summary states its model.
What the phenyl group changes
In the 1983 report, 4-phenylpiracetam activated operant behavior more strongly than piracetam. It countered diazepam's depressant effects. It also prevented retrograde amnesia. Unlike piracetam, it was anticonvulsant. At high amounts, it was itself depressant (Bobkov et al., 1983). Neither compound changed ligand binding at AMPA, NMDA or metabotropic glutamate receptors in rat brain tissue. This held from 0.1 nanomolar to 100 micromolar (Firstova et al., 2011). Models: mice, rats, guinea pigs and rat brain tissue.
R- and S-enantiomers
Phenotropil is used clinically as the racemate. In mice, single exposures raised open-field locomotor activity. This was seen at 10 and 50 mg/kg of the R-form and 50 mg/kg of the S-form. Both forms had antidepressant-like effects in the forced swim test. Only the R-form changed passive avoidance. It raised retention at 1 mg/kg. Yet brain levels of the two forms were similar (Zvejniece et al., 2011). Model: mice.
The dopamine transporter
Merz Pharmaceuticals coded the R-form MRZ-9547 (Dekundy et al., 2015). In vitro and in rat microdialysis, it selectively inhibited the dopamine transporter (DAT). It also moderately raised striatal dopamine release. Its mirror image, MRZ-9546, was much weaker. MRZ-9547 also raised rats' lever pressing for food on progressive ratio schedules. It did so more than methylphenidate did (Sommer et al., 2014). DAT was the only significant target for the R-form in a radioligand binding panel (Zvejniece et al., 2020).
The S-form is also called a selective DAT inhibitor. It was given daily by mouth to Western diet-fed mice for 8 weeks. Obese Zucker rats were given it the same way for 12 weeks. It lowered body weight gain and fat mass gain. It also lowered plasma glucose and leptin. It did not change locomotor activity (Zvejniece et al., 2017). Models: rats, mice and in vitro assays.
Neuroprotection and inflammation models
One study used Wistar rats with cerebral ischemia. The ischemia came from bilateral carotid occlusion or gravitational overload. Phenylpiracetam reduced neurological deficit. It preserved locomotor, exploratory and memory measures. It also raised survival and helped restore local cerebral blood flow. Piracetam had the same effects, but weaker (Tiurenkov et al., 2007).
Male mice were given bacterial lipopolysaccharide. One intraperitoneal exposure to the R-form lessened their fall in body temperature. It also lessened the rise in brain TNF-α, IL-1β and inducible nitric oxide synthase gene expression. A week of oral pretreatment reduced carrageenan-induced paw edema (Zvejniece et al., 2020). Models: rats and mice.
Clinical studies in Russia
A double-blind, randomized, placebo-controlled trial studied 90 adults with symptomatic focal epilepsy. They received phenylpiracetam at one of two daily amounts, or placebo. This was on top of standard antiepileptic drugs. The authors reported fewer seizures and better cognitive scores in those without epileptiform EEG abnormalities (Grebeniuk et al., 2014).
A 2025 meta-analysis pooled 11 studies in 549 people with asthenia, a fatigue syndrome. It reported MFI-20 fatigue scores 16.3 points lower on average after a one-month course. This was change over time rather than against placebo. Side effects were seen in 5.5 percent (Devlikamova and Safina, 2025). Model: human clinical studies.
Doping control and regulatory status
The World Anti-Doping Agency's 2026 Prohibited List names "Fonturacetam [4-phenylpiracetam (carphedon)]" among the S6.A non-specified stimulants. The list covers all optical isomers of listed stimulants. Fonturacetam is banned in competition. It was the first nootropic banned in sport, in 1998 (Jędrejko et al., 2023). Drugs@FDA lists no product containing it (openFDA search, October 2026).
A 2019 FDA warning letter covered one seller's phenylpiracetam. It was marketed with memory and focus claims. The letter called it an unapproved new drug, not a dietary supplement. European and Australian medicines control laboratories have intercepted bulk phenylpiracetam raw material. Its purity was close to 100 percent (Vanhee et al., 2025). Sources: regulators and market surveillance.
Key studies
- Tiurenkov IN, et al. "[Comparative evaluation of the neuroprotective activity of phenotropil and piracetam in laboratory animals with experimental cerebral ischemia]." Eksp Klin Farmakol. 2007. PMID 17523446. Rats: ischemia models, against piracetam.
- Zvejniece L, et al. "Investigation into stereoselective pharmacological activity of phenotropil." Basic Clin Pharmacol Toxicol. 2011. PMID 21689376. DOI 10.1111/j.1742-7843.2011.00742.x. Mice: R-form versus S-form.
- Sommer S, et al. "The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats." Int J Neuropsychopharmacol. 2014. PMID 24964269. DOI 10.1017/S1461145714000996. Rats: DAT inhibition by the R-form.
- Zvejniece L, et al. "Neuroprotective and anti-inflammatory activity of DAT inhibitor R-phenylpiracetam in experimental models of inflammation in male mice." Inflammopharmacology. 2020. PMID 32279140. DOI 10.1007/s10787-020-00705-7. Male mice: binding panel and inflammation models.
- Grebeniuk OV, et al. "[The efficacy of add-on treatment with phenotropil in adult patients with locally-induced epilepsy]." Zh Nevrol Psikhiatr Im S S Korsakova. 2014. PMID 25591651. DOI 10.17116/jnevro201411411227-31. 90 adults, placebo-controlled.
Handling and storage of phenylpiracetam spray
General lab practice for this material:
- Spray: an unopened bottle can stay at 15 to 25°C. The description recommends refrigeration after receipt. Once opened, keep it at 2 to 8°C, upright, closed and away from light. Never freeze it (storage guidance on the product page).
- The spray needs no reconstitution. Confirm its vehicle before planning vehicle controls.
- Record the lot number. For quantitative work, confirm the concentration by testing.
- For identity checks, compare data with C₁₂H₁₄N₂O₂ and 218.25 g/mol (the hydrazide: C₁₂H₁₅N₃O₂, 233.27 g/mol). Telling the enantiomers apart needs a chiral method. An amylose-based chiral column showed high recognition of 4-phenyl piracetam derivatives (Kažoka et al., 2013).
Frequently asked questions
What is phenylpiracetam?
Phenylpiracetam (PubChem CID 132441) is a racetam. It is piracetam with a phenyl group on its ring. It is a prescription drug in Russia (Vanhee et al., 2025). Rodent and binding studies tie its R-form to the dopamine transporter (Zvejniece et al., 2020).
What are fonturacetam and carphedon?
They are other names for phenylpiracetam. Fonturacetam is its International Nonproprietary Name. WADA lists it as fonturacetam [4-phenylpiracetam (carphedon)]. Russian papers also use the trade names Phenotropil (Grebeniuk et al., 2014) and Actitropil (Devlikamova and Safina, 2025).
Phenylpiracetam vs piracetam: what is the difference?
It adds a phenyl group at ring carbon 4. This raises the molecular weight from 142.16 to 218.25 g/mol (PubChem CIDs 4843 and 132441). It also creates R- and S-forms. In rodent tests, it was more active than piracetam. Unlike piracetam, it was anticonvulsant (Bobkov et al., 1983). Its R-form inhibits the dopamine transporter (Sommer et al., 2014).
Is phenylpiracetam banned?
In sport, yes. WADA's 2026 Prohibited List names fonturacetam [4-phenylpiracetam (carphedon)] among the S6.A non-specified stimulants. It is banned in competition. It was the first nootropic banned in sport, in 1998 (Jędrejko et al., 2023). It is also not an approved drug in the United States (Cohen et al., 2021). Nor is it authorised in the EU or Australia (Vanhee et al., 2025).
Is phenylpiracetam hydrazide the same compound?
No. PubChem lists the hydrazide (CID 4995664) on its own. Its side chain ends in a hydrazide, not an amide. No study in PubMed names it in a title or abstract (October 2026). So the research above does not describe it.
Has phenylpiracetam been studied in people?
Yes, as research history. It was studied in a randomized, placebo-controlled epilepsy trial (Grebeniuk et al., 2014). It also appears in asthenia studies pooled in a 2025 meta-analysis (Devlikamova and Safina, 2025). All the clinical studies in PubMed appeared in Russian journals.
Where can researchers buy phenylpiracetam?
Disguised Alpha sells phenylpiracetam for laboratory research as an aerosol spray, 250MCG per spray with an estimated 50 sprays per bottle: Phenylpiracetam Aerosol Spray. The Limitless aerosol blend also contains it.
Related compounds and guides
- Racetams explained
- Piracetam research guide
- Aniracetam research guide
- Oxiracetam research guide
- Noopept research guide
- Bromantane research guide
- What is a COA?
- COA portal
This product is for research use only. It has not been evaluated for safety or effectiveness in humans. Not for human consumption. All products are intended for laboratory research purposes only.